Malgorzata Szybka
Medical University Of Lodz. Pomorska Street 251 92-213 Lodz
Lodz, LD 92213, Poland
Lodz, LD 92213, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate.
Journal: Journal de mycologie medicale
Published: January 11, 2024
The role of heterodimer IL-17-A/F in atopic dermatitis.
Journal: Postepy dermatologii i alergologii
Published: January 31, 2022
Cytokine and LL-37 gene expression levels in Bartonella spp. seropositive and seronegative patients of a rheumatology clinic.
Journal: Advances in medical sciences
Published: September 25, 2021
The seroprevalence of Bartonella spp. in the blood of patients with musculoskeletal complaints and blood donors, Poland: a pilot study.
Journal: Clinical rheumatology
Published: January 23, 2019
MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients.
Journal: Archives of medical science : AMS
Published: February 02, 2017
Screening for THAP1 Mutations in Polish Patients with Dystonia Shows Known and Novel Substitutions.
Journal: PloS one
Published: February 27, 2015
Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line.
Journal: Oncology letters
Published: November 24, 2014
High variability of clinical symptoms in a Polish family with a novel THAP1 mutation.
Journal: The International journal of neuroscience
Published: November 12, 2014
PIN3 duplication may be partially responsible for TP53 haploinsufficiency.
Journal: BMC cancer
Published: March 24, 2014
TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status.
Journal: DNA and cell biology
Published: February 11, 2014
Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro.
Journal: Cancer cell international
Published: January 01, 2014
Last Updated: 09/26/2026